Funder: Cancer Research Institute
Due Dates: December 1, 2025: Letter of Intent (LOI) deadline | March 1, 2026: Full application deadline | March 2, 2026: Invited full proposal deadline
Funding Amounts: $300,000 over 2 years per award; possible renewal for an additional $300,000/2 years; up to 10% indirect costs above award amount
Summary: Supports translational cancer immunology research bridging laboratory discovery and clinical application, with special opportunities for chordoma-focused projects.
Key Information: No citizenship restrictions; open to faculty at non-profit research institutions worldwide.